SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 260 filers reported holding SAGE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $255,192 | -56.2% | 12,400 | 0.0% | 0.05% | -54.2% |
| Q2 2023 | $583,048 | -46.6% | 12,400 | -52.3% | 0.11% | -37.4% |
| Q1 2023 | $1,090,960 | +10.0% | 26,000 | 0.0% | 0.17% | +5.6% |
| Q4 2022 | $991,640 | -2.6% | 26,000 | 0.0% | 0.16% | -8.0% |
| Q3 2022 | $1,018,000 | +21.2% | 26,000 | 0.0% | 0.18% | +21.4% |
| Q2 2022 | $840,000 | -2.4% | 26,000 | 0.0% | 0.14% | -13.2% |
| Q1 2022 | $861,000 | -22.2% | 26,000 | 0.0% | 0.17% | -31.3% |
| Q4 2021 | $1,106,000 | -66.5% | 26,000 | -65.1% | 0.24% | -66.6% |
| Q3 2021 | $3,297,000 | -22.0% | 74,400 | 0.0% | 0.73% | -17.0% |
| Q2 2021 | $4,227,000 | – | 74,400 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |